Rhinitis
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Fatimo Biobaku M.B.B.S [2]
Synonyms and keywords: Allergic rhinitis; Hay fever; Seasonal allergic rhinitis; Perennial allergic rhinitis, Nonallergic rhinitis; Vasomotor rhinitis; Idiopathic rhinitis; Nonallergic rhinopathy; Gustatory rhinitis; NARES; Infectious rhinitis; Occupational rhinitis; Corrosive rhinitis; Atrophic rhinitis; Other rhinitis syndrome; Hormonally-induced rhinitis; Gestational rhinitis; Drug-induced rhinitis; Chemical rhinitis; Rhinitis medicamentosa
Overview
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Fatimo Biobaku M.B.B.S [2]
Overview
Rhinitis is a heterogenous disorder that is often treated with triviality.[1] It is a highly prevalent, global disease that can have significant impact on the quality of life of affected individuals.[2] Rhinitis is characterized by the presence of one or more nasal symptoms such as sneezing, nasal itching, rhinorrhea(anterior and posterior), and nasal congestion. There can be varying degrees of nasal inflammation.[3] It has a huge financial impact on the society, and generates between $1.6-$4.9 billion in direct expenditure in the US annually.[4] The estimated annual indirect cost from lost productivity in the US ranges between $0.1-$9.7 billion dollars.[4] Chronic rhinitis is one of the most common problems seen by physicians, and allergic rhinitis is the most common type of chronic rhinitis.[5][3] The prevalence of allergic rhinitis has been steadily increasing in various countries across the world.[6][7] Unfortunately, rhinitis is often overlooked, underdiagnosed, undertreated, and mistreated.[8] An understanding of the etiology of the different types of rhinitis and the treatment modalities, would improve the quality of care offered, and ultimately improve the quality of life of those who suffer from chronic rhinitis.
Historical Perspective
Rhinitis has been in existence since the ancient times. Seasonal allergic rhinitis (hay fever) evolved with the industrialization of westernized countries in the 19th century, and it was a common condition in Europe and North America by the end of the 19th century.[6] Nonallergic Rhinitis with Eosinophilic Syndrome(NARES) was first described in 1981 by Jacobs et al.[9] Primary atrophic rhinitis has been well known for ages to the ancient Egyptians, Greeks, and Indians, and it was first described by Bernhard Fraenkel in 1876.[10]
Classification
Rhinitis can be broadly classified into allergic and nonallergic rhinitis.[11] Some forms of rhinitis are not easily classified as either allergic or nonallergic,[11] and sometimes, there also appear to be an overlap of both allergic and nonallergic rhinitis (sometimes referred to as ‘mixed’ rhinitis).[5] The classification and diagnosis of nonallergic rhinitis is challenging due to its diverse etiology, and it is also not well understood compared to the allergic type.[12]
Pathophysiology
Allergic rhinitis is a multifactorial disease, its development is influenced by an interplay of genetic and environmental factors.[13] Aeroallergens in the nasal tissue undergo antigen processing, eliciting allergen-specific allergic responses and also promoting the development of allergic airway disease.[14][15] Proteins and glycoproteins in indoor and outdoor inhalant allergens such as dust mite fecal particles, cockroach residues, animal danders, molds, and pollens are common aeroallergens causing allergic rhinitis.[14][15] Allergic rhinitis is usually an IgE mediated disease with varying degrees of nasal inflammation. Nonallergic rhinitis is a heterogenous group with poorly defined and understood pathophysiology, and it consists of a variety of conditions which require more research and phenotyping.[16]
Causes
One of the most common diseases presenting to physicians is chronic rhinitis, and determination of the etiology is crucial to ensure appropriate management.[5] Allergic rhinitis is the most common type of chronic rhinitis,[3][17] and it is the fifth most common chronic ailment overall in the U.S.[17] Allergic rhinitis is triggered by the inhalation of indoor and outdoor aeroallergens such as pollens, molds, and animal dander.[6][15] Nonallergic rhinitis comprises a heterogenous group of disorders, some of which are still poorly defined and understood.[18] Nonallergic rhinitis can be induced by non-specific triggers such as exposure to chemical odors, cigarette smoke, spicy food, exercise, and cold air.[12]
Differentiating Rhinitis from other Diseases
It is important to differentiate rhinitis from other conditions micmicking the symptoms of rhinitis such as intranasal foreign bodies, cerebrospinal fluid rhinorrhea, nasal polyps and tumors.[19][3][6][20]
Epidemiology and Demographics
Rhinitis is a very frequent and highly prevalent global disease.[1] Allergic rhinitis is estimated to affect one in every six Americans, and it is the fifth most chronic disease in the U.S.[17] Allergic rhinitis is the most common chronic disease in the pediatric age group in the U.S,[17] and it was the most common diagnosis reported in the 2000 Otolaryngology Workforce study.[4] The estimated prevalence of allergic rhinitis ranges from 9-42%.[5] Annually, between 30-60 million people in the U.S suffer from allergic rhinitis, 10-30% of these individuals are adults, and up to 40% are children.[1] The prevalence of allergic rhinitis has been found to be increasing in countries worldwide, and factors such as increased airborne pollution, a rise in the population of dust mite in inadequately ventilated offices/homes with central heating/air conditioning, and sedentary lifestyles, have been suggested to contribute to the rise in its prevalence.[21][6][7] The prevalence of allergic rhinitis has significantly increased during the past 50 years, with over 50% of adolescents in some countries reporting symptoms of allergic rhinitis.[6] The prevalence of allergic rhinitis was noticed to have doubled in several countries over the last two decades in studies done in children between the ages 6-14years around the globe.[7] Nonallergic rhinitis is also very common, and it has been estimated to affect about 19 million people in the U.S.[5] “Mixed rhinitis” is estimated to affect about 26 million individuals in the United States.[5]
Risk factors
Risk factors for allergic rhinitis include a history of other atopic diseases such as asthma and atopic dermatitis, and a history of rhinitis in the parent.[22][23] Some of the risk factors for infectious rhinitis are daycare attendance, young age, and exposure to air pollutants.[24]
Natural History, Complications and Prognosis
Allergic rhinitis rarely occurs in isolation, it is a product of a genetic predisposition, epigenetic events, and environmental exposures, and it is frequently associated with other forms of atopy such as eczema, asthma, and allergic eye disease(allergic rhinoconjunctivitis).[25][26][4] The vast majority of individuals with asthma have rhinitis, and allergic eye disease has been reported to affect almost all patients with allergic rhinitis.[25][6] Nonallergic rhinitis is also associated with asthma.[27][6] Frequent extension of rhinitis (especially infectious rhinitis) into the sinuses also occur, resulting in rhinosinusitis.[15][1] Children with nonallergic rhinitis have a higher likelihood of undergoing remission, compared with those with allergic rhinitis, who tend to have a more persistent disease.[27] Remission occurs in up to 73% of four year old children with nonallergic rhinitis by the age of eight years.[27] Rhinitis is a significant cause of lost school and work days, and it constitutes a huge financial burden to the society.[21][2] Untreated/poorly treated chronic rhinitis is associated with a diminished quality of life, disordered sleep, impaired work performance, and several other comorbidities.[1][26]
History and Symptoms
It is pertinent to obtain the history of the symptoms of rhinitis, and also ask about the symptoms that are most bothersome to the patient. The pattern of the symptoms, precipitating factors, environmental history, coexisting conditions, family history, and previous response to medications, should all be obtained.[20][6][15][2]
Physical Examination
A careful history and physical examination is essential for accurate diagnosis, treatment, and prevention of the potential complications associated with chronic rhinitis.[8][5] It is essential to examine all the organ systems that are potentially affected by allergies.[2] A detailed examination of the upper respiratory tract should be done in all patients presenting with rhinitis.[2]
Laboratory Findings
Allergic rhinitis can be confirmed by recording specific IgE reactivity to relevant aeroallergens in the patient’s history, via skin testing(skin-prick/intradermal test) or serum specific IgE testing known as the radioallergosorbent test(RAST).[20][28][29][15]
X ray
Chest x-ray is of no clinical importance in the diagnosis of rhinitis, unless it is necessary for the evaluation of some associated comorbid conditions.
CT
Imaging studies such as CT scan are not routinely required for the diagnosis of rhinitis. However, a CT scan may be required when further evaluation is needed, such as in cases of complicated rhinosinusitis or when other pathological conditions are suspected. CT scans are also usually indicated for the evaluation of atrophic rhinitis.
Other Diagnostic Studies
Nasal endoscopy is a very good technique for detecting sinonasal pathologies as well as anatomical variations that are not accessible on anterior rhinoscopy, and it should be considered in the early diagnosis of various sinonasal diseases to ensure a complete examination of the nose and sinuses.[29]
Medical Therapy
The etiology and severity of rhinitis often determines the type of medical therapy offered. The commonly used medications are antihistamines and corticosteroids. Avoidance of triggers when possible, and saline irrigation of the nose also has clear benefits. Allergen-specific immunotherapy is also indicated for the treatment of allergic rhinitis in appropriately selected patients.[30]
Surgery
Surgery is not commonly required for the management of rhinitis. Surgical procedures are however, sometimes indicated in the management of structural/mechanical problems, or coexisting comorbid conditions.[3]
References
- ↑ 1.0 1.1 1.2 1.3 1.4 Romeo, Jonathan; Dykewicz, Mark (2014). “Chapter 9:Differential Diagnosis of Rhinitis and Rhinosinusitis”. Diseases of the Sinuses. Springer New York. pp. 133–152. ISBN 978-1-4939-0265-1.
- ↑ 2.0 2.1 2.2 2.3 2.4 Wallace DV, Dykewicz MS, Bernstein DI, Blessing-Moore J, Cox L, Khan DA; et al. (2008). “The diagnosis and management of rhinitis: an updated practice parameter”. J Allergy Clin Immunol. 122 (2 Suppl): S1–84. doi:10.1016/j.jaci.2008.06.003. PMID 18662584.
- ↑ 3.0 3.1 3.2 3.3 3.4 Sacre-Hazouri JA (2012). “[Chronic rhinosinusitis in children]”. Rev Alerg Mex. 59 (1): 16–24. PMID 24007929.
- ↑ 4.0 4.1 4.2 4.3 Mims JW (2014). “Epidemiology of allergic rhinitis”. Int Forum Allergy Rhinol. 4 Suppl 2: S18–20. doi:10.1002/alr.21385. PMID 25182349.
- ↑ 5.0 5.1 5.2 5.3 5.4 5.5 5.6 Settipane RA, Charnock DR (2007). “Epidemiology of rhinitis: allergic and nonallergic”. Clin Allergy Immunol. 19: 23–34. PMID 17153005.
- ↑ 6.0 6.1 6.2 6.3 6.4 6.5 6.6 6.7 6.8 Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A; et al. (2008). “Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)”. Allergy. 63 Suppl 86: 8–160. doi:10.1111/j.1398-9995.2007.01620.x. PMID 18331513.
- ↑ 7.0 7.1 7.2 Katelaris CH, Lee BW, Potter PC, Maspero JF, Cingi C, Lopatin A; et al. (2012). “Prevalence and diversity of allergic rhinitis in regions of the world beyond Europe and North America”. Clin Exp Allergy. 42 (2): 186–207. doi:10.1111/j.1365-2222.2011.03891.x. PMID 22092947.
- ↑ 8.0 8.1 Skoner DP (2001). “Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis”. J Allergy Clin Immunol. 108 (1 Suppl): S2–8. PMID 11449200.
- ↑ Ellis AK, Keith PK (2006). “Nonallergic rhinitis with eosinophilia syndrome”. Curr Allergy Asthma Rep. 6 (3): 215–20. PMID 16579871.
- ↑ Shehata MA (1996). “Atrophic rhinitis”. Am J Otolaryngol. 17 (2): 81–6. PMID 8820180.
- ↑ 11.0 11.1 Wallace DV, Dykewicz MS, Bernstein DI, Blessing-Moore J, Cox L, Khan DA; et al. (2008). “The diagnosis and management of rhinitis: an updated practice parameter”. J Allergy Clin Immunol. 122 (2 Suppl): S1–84. doi:10.1016/j.jaci.2008.06.003. PMID PMID:18662584 Check
|pmid=value (help). - ↑ 12.0 12.1 Paraskevopoulos, Giannis; Kalogiros, Lampros (March 2016). “Non-Allergic Rhinitis”. Current Treatment Options in Allergy. Volume 3 (Issue 1): 45–68. doi:10.1007/s40521-016-0072-6. Retrieved January 5, 2017.
- ↑ Sin B, Togias A (2011). “Pathophysiology of allergic and nonallergic rhinitis”. Proc Am Thorac Soc. 8 (1): 106–14. doi:10.1513/pats.201008-057RN. PMID 21364228.
- ↑ 14.0 14.1 Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A; et al. (2008). “Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)”. Allergy. 63 Suppl 86: 8–160. doi:10.1111/j.1398-9995.2007.01620.x. PMID 18331513 PMID: 18331513 Check
|pmid=value (help). - ↑ 15.0 15.1 15.2 15.3 15.4 15.5 Dykewicz MS, Hamilos DL (2010). “Rhinitis and sinusitis”. J Allergy Clin Immunol. 125 (2 Suppl 2): S103–15. doi:10.1016/j.jaci.2009.12.989. PMID 20176255.
- ↑ Sin B, Togias A (2011). “Pathophysiology of allergic and nonallergic rhinitis”. Proc Am Thorac Soc. 8 (1): 106–14. doi:10.1513/pats.201008-057RN. PMID 21364228.
- ↑ 17.0 17.1 17.2 17.3 Seidman MD, Gurgel RK, Lin SY, Schwartz SR, Baroody FM, Bonner JR; et al. (2015). “Clinical practice guideline: allergic rhinitis executive summary”. Otolaryngol Head Neck Surg. 152 (2): 197–206. doi:10.1177/0194599814562166. PMID 25645524.
- ↑ Sin B, Togias A (2011). “Pathophysiology of allergic and nonallergic rhinitis”. Proc Am Thorac Soc. 8 (1): 106–14. doi:10.1513/pats.201008-057RN. PMID 21364228.
- ↑ Dykewicz MS, Hamilos DL (2010). “Rhinitis and sinusitis”. J Allergy Clin Immunol. 125 (2 Suppl 2): S103–15. doi:10.1016/j.jaci.2009.12.989. PMID 20176255 20176255 Check
|pmid=value (help). - ↑ 20.0 20.1 20.2 Rotiroti, Giuseppina; Scadding, Glenis (July 2016). “Allergic Rhinitis-an overview of a common disease”. Paediatrics and Child Health. Volume 26 (Issue 7): 298–303. Retrieved January 20, 2017.
- ↑ 21.0 21.1 Schoenwetter WF, Dupclay L, Appajosyula S, Botteman MF, Pashos CL (2004). “Economic impact and quality-of-life burden of allergic rhinitis”. Curr Med Res Opin. 20 (3): 305–17. doi:10.1185/030079903125003053. PMID 15025839.
- ↑ Baumann LM, Romero KM, Robinson CL, Hansel NN, Gilman RH, Hamilton RG; et al. (2015). “Prevalence and risk factors for allergic rhinitis in two resource-limited settings in Peru with disparate degrees of urbanization”. Clin Exp Allergy. 45 (1): 192–9. doi:10.1111/cea.12379. PMID 25059756.
- ↑ Song N, Shamssain M, Mohammed S, Zhang J, Wu J, Fu C; et al. (2014). “Prevalence, severity and risk factors of asthma, rhinitis and eczema in a large group of Chinese schoolchildren”. J Asthma. 51 (3): 232–42. doi:10.3109/02770903.2013.867973. PMID 24303994.
- ↑ Passioti M, Maggina P, Megremis S, Papadopoulos NG (2014). “The common cold: potential for future prevention or cure”. Curr Allergy Asthma Rep. 14 (2): 413. doi:10.1007/s11882-013-0413-5. PMID 24415465.
- ↑ 25.0 25.1 Shaker M, Salcone E (2016). “An update on ocular allergy”. Curr Opin Allergy Clin Immunol. 16 (5): 505–10. doi:10.1097/ACI.0000000000000299. PMID 27490123.
- ↑ 26.0 26.1 Sacre Hazouri JA (2006). “[Allergic rhinitis. Coexistent diseases and complications. A review and analysis]”. Rev Alerg Mex. 53 (1): 9–29. PMID 16634358.
- ↑ 27.0 27.1 27.2 Westman M, Stjärne P, Asarnoj A, Kull I, van Hage M, Wickman M; et al. (2012). “Natural course and comorbidities of allergic and nonallergic rhinitis in children”. J Allergy Clin Immunol. 129 (2): 403–8. doi:10.1016/j.jaci.2011.09.036. PMID 22056609.
- ↑ Seidman MD, Gurgel RK, Lin SY, Schwartz SR, Baroody FM, Bonner JR; et al. (2015). “Clinical practice guideline: Allergic rhinitis”. Otolaryngol Head Neck Surg. 152 (1 Suppl): S1–43. doi:10.1177/0194599814561600. PMID 25644617.
- ↑ 29.0 29.1 K Maru Y, Gupta Y (2016). “Nasal Endoscopy Versus Other Diagnostic Tools in Sinonasal Diseases”. Indian J Otolaryngol Head Neck Surg. 68 (2): 202–6. doi:10.1007/s12070-014-0762-y. PMC 4899354. PMID 27340637.
- ↑ Cox L, Nelson H, Lockey R, Calabria C, Chacko T, Finegold I; et al. (2011). “Allergen immunotherapy: a practice parameter third update”. J Allergy Clin Immunol. 127 (1 Suppl): S1–55. doi:10.1016/j.jaci.2010.09.034. PMID 21122901.
Historical Perspective
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Fatimo Biobaku M.B.B.S [2]
Overview
Rhinitis is a frequent disease with varied etiology. It has been in existence since the ancient times, and some forms of rhinitis have been vaguely described as far back as the 9th century.
Historical Perspective
Rhinitis is a very common disease, and it consists of a heterogeneous group of disorders. Rhinitis has been described with terminologies such as “catarrh” as far back as the 15th century. The word “catarrh” was coined from the word “katarrhein” which means to flow down. The origin is from Greek(katarrhous), Middle English (catarre), Medieval French (catarrhe) and Late Latin(catarrhus). Rare descriptions of seasonal allergic rhinitis(hay fever) are seen in the 9th century in Islamic texts, and in the 16th century in European texts.[1] Hay fever is believed to have fully emerged with the industrialization of westernized countries in the 19th century.[1] The first detailed description of hay fever was in the early 19th century, and by the end of the 19th century, it was a common condition in Europe and North America.[1] The “hygiene hypothesis” became popular in the late 1980s, and the hypothesis linked the high prevalence of atopic disorders in developed countries to the lack of antigenic stimuli, which occurs as a result of improved hygiene, vaccination, and antibiotic use. Thus, the human immune system is altered such that it responds inappropriately to innocuous environmental substances.[2] Nonallergic Rhinitis with Eosinophilic Syndrome(NARES) was first described in 1981 by Jacobs et al.[3] Primary atrophic rhinitis has been well known for ages to the ancient Egyptians, Greeks, and Indians. There is evidence that date wine and milk were prescribed for the treatment of primary atrophic rhinitis about 4000 years ago, in the ancient Egyptian medical text ( Edwin Smith Papyrus).[4] Primary atrophic rhinitis was first described by Bernhard Fraenkel in 1876.[4]
References
- ↑ 1.0 1.1 1.2 Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A; et al. (2008). “Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)”. Allergy. 63 Suppl 86: 8–160. doi:10.1111/j.1398-9995.2007.01620.x. PMID 18331513.
- ↑ Kim DS, Drake-Lee AB (2003). “Infection, allergy and the hygiene hypothesis: historical perspective”. J Laryngol Otol. 117 (12): 946–50. doi:10.1258/002221503322683812. PMID 14738603.
- ↑ Ellis AK, Keith PK (2006). “Nonallergic rhinitis with eosinophilia syndrome”. Curr Allergy Asthma Rep. 6 (3): 215–20. PMID 16579871.
- ↑ 4.0 4.1 Shehata MA (1996). “Atrophic rhinitis”. Am J Otolaryngol. 17 (2): 81–6. PMID 8820180.
Classification
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Fatimo Biobaku M.B.B.S [2]
Overview
Rhinitis can be broadly classified into allergic and nonallergic rhinitis.[1] Some forms of rhinitis are not easily classified as either allergic or nonallergic,[1] and sometimes, there also appear to be an overlap of both allergic and nonallergic rhinitis (sometimes referred to as ‘mixed’ rhinitis).[2] The classification and diagnosis of nonallergic rhinitis is challenging due to its diverse etiology, and it is also not well understood compared to the allergic type.[3]
Classification
- Rhinitis can be broadly classified into allergic and nonallergic rhinitis, however, some forms of rhinitis cannot be easily classified into these two categories.[1] An understanding of the fact that there is no widely accepted and scientifically valid classification of the various forms of rhinitis is essential, this is mostly due to the poor phenotyping of the forms of rhinitis that do not fall under the allergic and infectious categories.[4] A comprehensive classification of rhinitis based on the etiology is depicted in the table below:
| Classification of Rhinitis[1][5][6][7] | ||
|---|---|---|
| Class | Types/causes | |
| Allergic rhinitis | US Joint Task Force on Practice Parameters(JTF) classification of allergic rhinitis | Seasonal (hay fever) |
| Perennial | ||
| Episodic
(Triggered by sporadic exposure to aeroallergens not normally present in the patient’s environment) | ||
| Allergic Rhinitis and its Impact on Asthma(ARIA) classification of allergic rhinitis | Intermittent | |
| Persistent | ||
| Nonallergic rhinitis | Vasomotor rhinitis | Irritant triggered |
| Cold air/Dry air | ||
| Exercise | ||
| Emotional | ||
| Sexual activity[8] | ||
| Undetermined or poorly defined triggers | ||
| Gustatory rhinitis | ||
| Infectious(viral, bacterial, fungal, parasitic) | Acute | |
| Chronic | ||
| NARES
(Nonallergic rhinitis with eosinophilia syndrome) |
||
| Occupational rhinitis | IgE-mediated
(caused by protein and chemical allergens) |
|
| Immune mechanism uncertain
(caused by chemical respiratory sensitizers) | ||
| Work-exacerbated/work-aggravated rhinitis
(occurs in nonoccupational settings but it is aggravated by work exposure) | ||
| Other rhinitis syndromes | Hormonally-induced | Gestational |
| Menstrual cycle related | ||
Drug-induced[9]
|
Rhinitis medicamentosa | |
| Oral contraceptives | ||
| Antihypertensives and cardiovascular agents | ||
| Aspirin/NSAIDs | ||
| Other drugs such as phosphodiesterase-5 selective inhibitors | ||
| Atrophic rhinitis | Primary atrophic rhinitis– causes include:
| |
Secondary atrophic rhinitis– causes include:
| ||
| Rhinitis associated with inflammatory-immunologic disorders | Granulomatous infections | |
| Wegener granulomatosis | ||
| Sarcoidosis | ||
| Sjogren’s syndrome | ||
| Midline granuloma | ||
| Churg-Strauss syndrome | ||
| Relapsing polychondritis | ||
| Amyloidosis | ||
- Allergic rhinitis can also be graded by the level of severity. However, there is no generally accepted method for grading the severity of allergic rhinitis.[1]
| Modified Classification of Allergic Rhinitis According to Severity of Symptoms and Quality of Life Impairment[10][7][11]
| |
|---|---|
| Type of allergic rhinitis | Clinical characteristic |
| Intermittent | Symptoms are present on fewer than four days a week and for less than four weeks |
| Persistent | Symptoms are present on more than four days a week and for more than four consecutive weeks |
| |
References
- ↑ 1.0 1.1 1.2 1.3 1.4 Wallace DV, Dykewicz MS, Bernstein DI, Blessing-Moore J, Cox L, Khan DA; et al. (2008). “The diagnosis and management of rhinitis: an updated practice parameter”. J Allergy Clin Immunol. 122 (2 Suppl): S1–84. doi:10.1016/j.jaci.2008.06.003. PMID PMID:18662584 Check
|pmid=value (help). - ↑ Settipane RA, Charnock DR (2007). “Epidemiology of rhinitis: allergic and nonallergic”. Clin Allergy Immunol. 19: 23–34. PMID 17153005.
- ↑ Paraskevopoulos, Giannis; Kalogiros, Lampros (March 2016). “Non-Allergic Rhinitis”. Current Treatment Options in Allergy. Volume 3 (Issue 1): 45–68. doi:10.1007/s40521-016-0072-6. Retrieved January 5, 2017.
- ↑ Sin B, Togias A (2011). “Pathophysiology of allergic and nonallergic rhinitis”. Proc Am Thorac Soc. 8 (1): 106–14. doi:10.1513/pats.201008-057RN. PMID 21364228.
- ↑ Sacre-Hazouri JA (2012). “[Chronic rhinosinusitis in children]”. Rev Alerg Mex. 59 (1): 16–24. PMID 24007929 PMID: 24007929 Check
|pmid=value (help). - ↑ Romeo, Jonathan; Dykewicz, Mark (2014). “Chapter 9:Differential Diagnosis of Rhinitis and Rhinosinusitis”. Diseases of the Sinuses. Springer New York. pp. 133–152. ISBN 978-1-4939-0265-1.
- ↑ 7.0 7.1 Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A; et al. (2008). “Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)”. Allergy. 63 Suppl 86: 8–160. doi:10.1111/j.1398-9995.2007.01620.x. PMID 18331513.
- ↑ Monteseirin J, Camacho MJ, Bonilla I, Sánchez-Hernández C, Hernández M, Conde J (2001). “Honeymoon rhinitis”. Allergy. 56 (4): 353–4. PMID 11284809.
- ↑ Varghese M, Glaum MC, Lockey RF (2010). “Drug-induced rhinitis”. Clin Exp Allergy. 40 (3): 381–4. doi:10.1111/j.1365-2222.2009.03450.x. PMID 20210811.
- ↑ Sacre-Hazouri JA (2012). “[Chronic rhinosinusitis in children]”. Rev Alerg Mex. 59 (1): 16–24. PMID pmid24007929 Check
|pmid=value (help). - ↑ Van Hoecke H, Vastesaeger N, Dewulf L, De Bacquer D, van Cauwenberge P (2006). “Is the allergic rhinitis and its impact on asthma classification useful in daily primary care practice?”. J Allergy Clin Immunol. 118 (3): 758–9. doi:10.1016/j.jaci.2006.05.015. PMID 16950299.
Pathophysiology
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Fatimo Biobaku M.B.B.S [2]
Overview
Rhinitis is a term that refers to a heterogeneous group of nasal disorders characterized by the presence of one or more nasal symptoms such as sneezing, nasal itching, rhinorrhea(anterior and posterior), and nasal congestion.[1] It is broadly classified into allergic and nonallergic rhinitis, although some forms of rhinitis cannot be easily classified into these categories.[2] Allergic rhinitis is a multifactorial disease, its development is influenced by an interplay of genetic and environmental factors.[3] Aeroallergens in the nasal tissue undergo antigen processing, eliciting allergen-specific allergic responses and also promoting the development of allergic airway disease.[4][5] Proteins and glycoproteins in indoor and outdoor inhalant allergens such as dust mite fecal particles, cockroach residues, animal danders, molds, and pollens are common aeroallergens causing allergic rhinitis.[4][5] Allergic rhinitis is usually an IgE mediated disease with varying degrees of nasal inflammation. Nonallergic rhinitis is a heterogenous group with poorly defined and understood pathophysiology, and it consists of a variety of conditions which require more research and phenotyping.[6]
Pathophysiology

Nose
It is both a respiratory and an olfactory organ. The nose is a highly vascular organ, the nasal blood vessels receive parasympathetic innervation and dense sympathetic innervation. Parasympathetic nerve stimulation promotes nasal secretion and mucus gland production which can result in nasal congestion, while sympathetic nerve stimulation causes a reduction in nasal blood flow, and significant nasal decongestion of the venous erectile tissues in the nose. The nasal cavity is divided into right and left halves by the nasal septum. The nasal cavity extends from the vestibule to the nasopharynx, and it is generally divided into three parts namely:
- The vestibule- the area which surrounds the external opening to the nasal cavity.
- The olfactory region- located at the apex of the nasal cavity, it is lined by olfactory cells.
- The respiratory region- this is the largest part of the nasal cavity. The turbinates/conchae project from the lateral wall of the nasal cavity, and they promote air filtration, humidification and temperature regulation.The respiratory region is lined by pseudostratified columnar epithelial cells(about 80% of these cells are ciliated). Interspersed within the epithelium are mucus-secreting goblet cells which are necessary for the maintenance of mucociliary clearance. Factors such as dryness and temperature significantly affect the ciliary function of epithelial cells. Ciliary action stops after 8-10mins at 50% relative humidity of inspired air, and after 3-5mins at 30% relative humidity of inspired air. Ciliary activity ceases at temperatures between 7-120C. Significant impairment of ciliary function can also occur due to factors such as environmental exposure to large amounts of wood dust and chromium vapors, tobacco smoke, inhaled gases, locally applied drugs, infection. Ciliary structure changes has been noted in patients with longstanding allergic rhinitis.
Paranasal sinuses
The paranasal sinuses drain into the nasal cavity. The nose and sinuses are contiguous structures, and they share vascular, neuronal and interconnecting anatomic pathways.
Allergic rhinitis is an IgE mediated disease. Genetic predisposition and environmental factors significantly influence its development. Proteins and glycoproteins (and rarely, glycans) in indoor and outdoor inhalant allergens such as pollens, molds, dust mite fetal particles, coakroach residues, and animal danders, are commonly implicated. The inherent enzymatic proteolytic activity of aeroallergens promote their access to antigen presenting cells by cleaving tight junctions in the airway epithelium and also via activation of receptors on epithelial cells. These activated epithelial cells produce proinflammatory mediators (such as cytokines, chemokines, thymic stromal lymphopoietin) which interact with subepithelial and interepithelial dendritic cells. Adaptive allergic sensitization occurs via the following processes:
- Antigen presenting cells (dendritic cells expressing CD1a and CD11c and macrophages) process nasal allergens in the epithelial mucosa of the nose.
- These antigen presenting cells then present the allergenic peptides by MHC class II molecules to T-cell receptors on naive CD4+ T lymphocytes in regional lymph nodes.
- Costimulatory signals result in the proliferation of allergen-stimulated T-cells into TH2-biased cells which release cytokines such as interleukins (IL-3, IL-4, IL-5, IL-13) and other cytokines.
- These cytokines lead to a cascade of events which promote B-cell isotype switching with subsequent local and systemic allergen-specific IgE antibody production by plasma cells.
- Allergen-specific IgE antibodies then become fixed to the high affinity receptor for IgE on the membranes of mast cells and basophils, rendering them sensitized.
Following sensitization, exposure to specific allergen result in the following:
- Aggregation of receptor-bound IgE molecules interact with the allergen( IgE–allergen interaction) within minutes.
- IgE–allergen interaction result in the degranulation of mast cells and basophils with the release of preformed mediators such as histamine and tryptase, and the rapid de novo generation of other mediators, including cysteinyl leukotrienes (LTC4, LTD4, LTE4) and prostaglandins (primarily PGD2), producing the allergic response which result in itching, sneezing, rhinorrhoea and blockage in the nose.
Mediators and cytokines released during the early response also act on postcapillary endothelial cells, promoting the expression of adhesion molecules(such as intercellular adhesion molecule 1, E-selectin, and vascular cell adhesion molecule 1). These adhesion molecules promote the adherence of circulating leukocytes, such as eosinophils, to endothelial cells. Factors with chemoattractant properties( such as IL-5 for eosinophils) also promote the infiltration of the superficial lamina propria of the mucosa with many eosinophils, some neutrophils and basophils, and eventually CD4+ (TH2) lymphocytes and macrophages. These cells become activated and release more mediators, which in turn activate many of the proinflammatory reactions seen in the immediate response. The role of IgE-mediated reaction in rhinitis and asthma have been further confirmed by the effect of an anti-IgE monoclonal antibody in these diseases.
Microscopic Pathology
Studies of cells infiltrating the nasal mucosa during the pollen season show increment in the amount of various inflammatory cells which correlates with the severity of symptoms and nasal nonspecific hyperactivity.
- Eosinophils are almost always found in the mucosa between nondesquamated epithelial cells, in the submucosa and in nasal secretions.
- Degranulated mast cells are present in increased numbers in the epithelium and the submucosa.
- CD4+ T-cells and Langerhan-like cells (CD1+) are increased in number during the pollen season
Pathogenesis of Nonallergic Rhinitis
Nonallergic rhinitis encompasses a heterogeneous group of nasal conditions with diverse pathophysiology.[10] Unlike allergic rhinitis, nonallergic rhinitis is characterized by periodic, seasonal, persistent or perennial symptoms of rhinitis not resulting from IgE-dependent events.[10][11] Imbalance in the maintenance of homeostasis between vasoconstriction and vasodilation of nasal vasculature and the secretion of nasal glands by sympathetic and parasympathetic components of the autonomic nervous system contribute to glandular hypersecretion and increased nasal congestion.[12] Neuropeptides secreted by unmyelinated nociceptive C fibers (tachykinins, calcitonin gene-related peptide, neurokinin A, gastrin-releasing peptide) and parasympathetic nerve endings (vasoactive intestinal peptide), have recently been established to be present in the nasal mucosa. Rhinitis can occur via the following mechanism:
- Exposure to nonallergic triggers result in the activation of Transient Receptor Potential cation channels (TRPV1, TRPA1) on nasal mucosal nerve fibers
- This results in the release of neuropetides such as Calcitonin Gene-Related Peptide (CGRP)and substance P from sensory nerve endings.[12]
- These neuropeptides facilitate vasodilation and plasma extravasation, resulting in edema and glandular hypersecretion.[12] It is important to note that the evidence for substance P involvement was extrapolated following the beneficial effect of treatment with capsaicin (known to deplete substance P from sensory nerve endings) in affected patients.[12]
- These pathophysiologic mechanisms have not been extensively investigated.[12]
Subtypes of nonallergic rhinitis include:
- Vasomotor/idiopathic rhinitis– This is also sometimes referred to as nonallergic rhinopathy because there is a lack of nasal mucosal inflammation.[13] The pathogenesis is unclear although neurosensory abnormalities have been suggested.[14][13] The nasal mucosa of patients with vasomotor rhinitis is indistinguishable from those of normal subjects.[14] Vasomotor rhinitis is a chronic nasal condition usually without eosinophilia.[11] It has been found to be associated with vasospastic disorders such as primary acrocyanosis.[15] Triggers of vasomotor rhinitis include:[13][1][16]
- Climatic changes(e.g humidity, temperature, barometric pressure)
- Irritants like strong smells (such as perfumes, cooking smells, flowers, and chemical odors), environmental tobacco smoke, pollutants and chemicals
- Exercise
- Trauma[17]
- Emotional
- Sexual activity[18]
Honeymoon rhinitis[18] – This occurs as a result of sexual activity, and it is a rare trigger of rhinitis. Strong emotions, excitement and anxiety have been proposed as the triggers for honeymoon rhinitis. One of the proposed mechanism for honeymoon rhinitis is the increased parasympathetic activity toward the culmination in orgasm. Release of mast cell mediators following cholinergic stimulation has also been proposed to cause postcoital rhinitis in patients experiencing honeymoon rhinitis.
- Gustatory rhinitis– This is a type of nonallergic rhinitis that occurs following solid/liquid food ingestion.[11][19][20] It is due to an abnormal gustatory reflex that is associated with a hyperactive neural system.[19] Ethanol in alcoholic beverages have also been proposed to cause pharmacologic vasodilation.[5] Unilateral/bilateral watery rhinorrhea often occurs within few minutes of ingestion of the implicated food.[20] It is seldom associated with nasal itching/congestion or facial pain.[20] Occasionally, it is associated with a significant impairment in the quality of life of the affected individual.[19] Common triggers of gustatory rhinitis are alcohol, hot and spicy food.[20][11] Rhinitis from food allergy can also occur but it usually presents with associated gastrointestinal, dermatologic, or systemic manifestations.[11]
- Infectious rhinitis– Viral infections account for up to 98% of acute infectious rhinitis, and it is the cause of the majority of rhinitis cases in young children.[11] Infectious rhinitis is commonly associated with rhinosinusitis because of the contiguous nature of the nose and sinuses, and often times, there is an overlap in the clinical presentation, which make differentiation between the two diagnosis difficult.[21] Symptoms usually resolve within 7-10 days of onset.[21] Pruritus is not a typical finding in infectious rhinitis.[5]
- Nonallergic rhinitis with eosinophilia syndrome(NARES)-The Pathophysiology of NARES is not well understood, but affected individuals demonstrate chronic eosinophilic inflammation similar to that found in allergic rhinitis. However, unlike allergic rhinitis, the patients lack evidence of allergic disease based on skin testing or serum levels of IgE to environmental allergens.[22][5] Analysis of nasal cytology often demonstrate more than 20% eosinophils (the range between 5% to more than 20% is recommended by some clinicians for the diagnosis of NARES).[22][5] Histology of the nasal mucosal biopsy in patients with NARES show mast cells with bound IgE and increased tryptase, identical to that found in allergic rhinitis.[5] Nasal congestion occurs frequently.[5] Other perennial nasal symptoms seen in NARES include; sneezing paroxysms, profuse watery rhinorrhea, nasal pruritus, and occasional Anosmia.[5] It is believed to be a risk factor for nasal polyposis, aspirin sensitivity and obstructive sleep apnea.[22][5]
Pathogenesis of Occupational Rhinitis
Occupational rhinitis occurs in response to airborne substances in the workplace.[11] It sometimes coexists with occupational asthma.[11] Occupational rhinitis can be triggered via allergic and nonallergic mechanisms.[11][21][23]. The pathophysiology of some types of occupational rhinitis is still poorly understood.[21]
Allergic occupational rhinitis– can occur following sensitization to a particular allergen at the workplace, which then results in immunologic response mediated by specific IgE antibodies following re-exposure to the allergen.[23][24] Small molecular weight chemicals in occupational agents can also act as haptens, and they react with self-proteins in the airway to form complete allergens.[5]
Nonallergic occupational rhinitis– mechanisms that involve damage to the epithelium, neurokinin release, and nociceptors have been proposed in the pathogenesis.[5]
Different forms of occupational rhinitis have been described in the literature using various names such as:
- Rhinitis primarily caused by work exposure (occupational rhinitis); and
- Rhinitis aggravated by exposure to work (work-exacerbated rhinitis).
- Work-exacerbated/work-aggravated rhinitis[11][21] – Rhinitis concurrently occurs in non-occupational settings, but found to be worsened by occupational exposures.
- Irritant-induced occupational rhinitis[24][21] – Inflammation of the nasal mucosa is seen without apparent immunologic or allergic basis. It occurs following exposure to chemicals, pesticides, etc.
- Corrosive rhinitis[21][24] – Sometimes described as a type of irritant-induced rhinitis. It has been found to occur following repeated exposures to corrosives such as chromium. Chronic inflammation is seen, which may progress to ulcerations and perforations of the nasal septum.
Pathogenesis of other Rhinitis Syndromes
Hormonally induced rhinitis – This comprises of gestational and menstrual cycle-related rhinitis. Theories have been proposed, however, the pathophysiology is still unclear.
- Gestational/pregnancy-induced rhinitis – defined as rhinitis presenting during pregnancy, and lasting for a duration of at least six weeks.[25] It usually occurs in the second or third trimester(it is not present before pregnancy), and evidence of upper respiratory infection or allergic etiology is absent.[25] The pathophysiology of gestational rhinitis is unknown.[25] However, hormone-induced vascular pooling has been suggested.[5][25] It is usually associated with significant nasal congestion.[11][5] Rhinorrhea also frequently occurs.[25] The involvement of the following hormones have been proposed:
- Placental trophoblastic hormone during pregnancy: Nasal mucosa hypertrophy is believed to occur as a result of the stimulation by the placental trophoblastic hormone.[25]
- Progesterone: This probably increases nasal vasodilation through the physiologic increase in the circulating blood volume
- Estrogen may increase histamine receptors in the microvasculature and epithelial cells.[25]
However, the data on the role of these hormones is controversial.[25] Gestational rhinitis usually resolves within two weeks following delivery.[5][11][25] Smoking is a recognized risk factor for gestational rhinitis.[25] The association of gestational rhinitis with snoring and obstructive sleep apnea syndrome (and indirectly, preeclampsia) is of clinical importance, and it is gradually getting more attention.[25] Some studies also show an association of gestational rhinitis with gestational hypertension, intrauterine growth restriction and newborns with a lower Apgar score.[25] Women with allergic rhinitis have also been reported to have worsening symptoms during pregnancy.[5]
Drug-induced rhinitis[5][26] – A number of oral and topical medications have been implicated in the etiology of drug-induced rhinitis. The pathophysiology of drug-induced rhinitis is not fully understood. Prolonged use of some medications such as α-adrenergic decongestant nasal sprays, intranasal cocaine and methamphetamine, have been noted to induce rebound nasal congestion following withdrawal (referred to as rhinitis medicamentosa). Repeated intranasal cocaine and methamphetamine can also result in septal erosion and perforation. Some other drugs known to cause drug-induced rhinitis are medications such as ACE inhibitors, β-blockers, phentolamine, aspirin, NSAIDS, oral contraceptives, phosphodiesterase-5–selective inhibitors. Drug-induced rhinitis can be divided into three types based on the proposed mechanism of action:[27]
- Local inflammatory type: Medications such as NSAIDS and aspirin are implicated. Several mechanisms via which these class of drugs cause rhinitis have been proposed. The commonly accepted theory is the induction of acute inflammatory response in the nose via inhibition of the cyclooxygenase-1(cox-1). This leads to a decrease in prostaglandin E2 (PG E2) and an increase in cysteinyl leukotrienes production by the lipooxygenase pathway.
- Neurogenic type: Adrenergic antagonists like clonidine, methyldopa and guanethidine are in this category. These medications down regulate the sympathetic tone via their sympatholytic activity, resulting in nasal congestion and blunted effects of norepinephrine and neuropeptide-Y. Phosphodiesterase-5 inhibitors such as sildenafil appear to worsen the nasal stuffinesss that occurs during sexual activity(honeymoon rhinitis) via its action on the nasal erectile tissues.
- Idiopathic type
- Rhinitis medicamentosa– It can also be referred to as rebound rhinitis or chemical rhinitis. It is a drug-induced nonallergic rhinitis, usually associated with prolonged use of topical nasal decongestant sprays. It is also occasionally used to describe nasal congestion secondary to oral medications. The pathophysiology is not fully understood, although several theories exist. There is controversial evidence of an association of rhinitis medicamentosa with the preservative; benzalkonium chloride (BKC), which is sometimes used in nasal spray preparations (for decongestants and glucocorticosteroids). Nasal mucosal changes that can be seen in rhinitis medicamentosa include loss of ciliated epithelial cells (this results in reduced mucociliary clearance), squamous cell metaplasia, increased mucus production and goblet cell hyperplasia. The nasal mucosa can appear beefy red on inspection.[27]
Atrophic rhinitis[28][29][21] – This is a chronic disease of the nose that is characterized by progresssive atrophy and resorption of the nasal mucosa, and underlying turbinates and bones. Foul-smelling nasal crusts(ozena) occur following the rapid drying of viscid nasal secretions. Abnormal patency of the nasal passages occur as a result of the atrophic changes. Atrophic rhinitis can be either primary or secondary.
- Primary/idiopathic atrophic rhinitis– The exact etiology is still unknown although several theories exist. Primary atrophic rhinitis is more commonly seen in developing countries with warm climates, and infection with Klebsiella ozaenae is most frequently implicated.
- Secondary atrophic rhinitis– This is usually caused by other primary conditions such as recurrent or chronic sinusitis, direct trauma, irradiation or excessive surgical removal of the nasal turbinates(empty nose syndrome), granulomatous nasal infections. It can be confused with rhinitis in the elderly (where structural changes in the connective tissue and vasculature secondary to aging occurs, resulting in rhinitis).
Rhinitis associated with inflammatory-immunologic disorders[21] – This form of rhinitis frequently precedes the overt systemic manifestations of the inflammatory-immunologic disorders.
- Granulomatous infections– Granulomatous nasal lesions with ulceration and formation of crusting, leading to nasal obstruction can occur secondary to certain types of infections. It is important to rule out infections such as tuberculosis, syphilis, leprosy, sporotrichosis, blastomycosis, histoplasmosis and coccidioidomycosis, when ulcerative nasal lesions are seen. Rhinoscleroma, a chronic granulomatous disease caused by Klebsiella rhinoscleromatis, can also result in nasal obstruction via the induction of a polyploid mass within the nasal cavity. Syphilitic infection in pregnant women can also result in congenital syphilitic rhinitis/rhinorrhea (snuffles) in the newborn.[30] Congenital syphilitic rhinitis, however, presents with other manifestations of congenital syphilis such as pseudoparalysis, maculopapular rash, respiratory distress, hemolysis with anemia, jaundice, thrombocytopenia and hepatosplenomegaly.[30] Congenital syphilis can present at birth or during infancy.[30]
- Wegener granulomatosis– This is a systemic autoimmune necrotising vasculitis. Nasal manifestations such as epistaxis, nasal congestion, purulent rhinorrhea and, crusting is common. Erosion and perforation of the nasal septum can occur resulting in a saddle nose deformity.
- Sjogren’s syndrome– It is a systemic autoimmune disease where exocrine gland destruction leads to generalized dryness. Nasal manifestations include granuloma formation, nasal dryness, epistaxis, nasal congestion. It can occasionally result in rhinosinusitis.
- Churg-Strauss syndrome/allergic granulomatosis– This is more appropriately known as eosinophilic granulomatosis with polyangiitis. It is a systemic autoimmune vasculitis associated with systemic granuloma formation. It affects medium and small vessels. It frequently manifests as asthma.. Other manifestations include chronic rhinosinusitis, nasal polyposis. Eosinophilia is commonly seen.
- Amyloidosis– Amyloid deposition in the nasopharynx can result in rhinitis symptoms such as nasal obstruction and postnasal discharge
- Midline granuloma– Midline granuloma usually occur in the nasal cavity and it is often lethal. It can present with symptoms of rhinitis such as nasal obstruction, rhinorrhea. A strong association of midline granuloma with EBV infection exists.
- Sarcoidosis– This is an Immune mediated granulomatous, chronic inflammatory disease. It is a rare cause of rhinitis.
- Relapsing polychondritis– This is a rare systemic autoimmune inflammatory disease. The features are highly variable and include chondritis in multiple sites of the body, inflammatory arthritis, ocular inflammation, etc. Nasal manifestations include nasal congestion, crusting, rhinorrhea, epistaxis.
References
- ↑ 1.0 1.1 Sacre-Hazouri JA (2012). “[Chronic rhinosinusitis in children]”. Rev Alerg Mex. 59 (1): 16–24. PMID 24007929.
- ↑ Settipane RA, Charnock DR (2007). “Epidemiology of rhinitis: allergic and nonallergic”. Clin Allergy Immunol. 19: 23–34. PMID 17153005.
- ↑ Sin B, Togias A (2011). “Pathophysiology of allergic and nonallergic rhinitis”. Proc Am Thorac Soc. 8 (1): 106–14. doi:10.1513/pats.201008-057RN. PMID 21364228.
- ↑ 4.0 4.1 4.2 Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A; et al. (2008). “Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)”. Allergy. 63 Suppl 86: 8–160. doi:10.1111/j.1398-9995.2007.01620.x. PMID 18331513 PMID: 18331513 Check
|pmid=value (help). - ↑ 5.00 5.01 5.02 5.03 5.04 5.05 5.06 5.07 5.08 5.09 5.10 5.11 5.12 5.13 5.14 5.15 5.16 5.17 Dykewicz MS, Hamilos DL (2010). “Rhinitis and sinusitis”. J Allergy Clin Immunol. 125 (2 Suppl 2): S103–15. doi:10.1016/j.jaci.2009.12.989. PMID 20176255.
- ↑ Sin B, Togias A (2011). “Pathophysiology of allergic and nonallergic rhinitis”. Proc Am Thorac Soc. 8 (1): 106–14. doi:10.1513/pats.201008-057RN. PMID 21364228.
- ↑ Jones N (2001). “The nose and paranasal sinuses physiology and anatomy”. Adv Drug Deliv Rev. 51 (1–3): 5–19. PMID 11516776.
- ↑ Watelet JB, Van Cauwenberge P (1999). “Applied anatomy and physiology of the nose and paranasal sinuses”. Allergy. 54 Suppl 57: 14–25. PMID 10565476.
- ↑ Sin B, Togias A (2011). “Pathophysiology of allergic and nonallergic rhinitis”. Proc Am Thorac Soc. 8 (1): 106–14. doi:10.1513/pats.201008-057RN. PMID 21364228.
- ↑ 10.0 10.1 Sin B, Togias A (2011). “Pathophysiology of allergic and nonallergic rhinitis”. Proc Am Thorac Soc. 8 (1): 106–14. doi:10.1513/pats.201008-057RN. PMID pmid21364228 Check
|pmid=value (help). - ↑ 11.00 11.01 11.02 11.03 11.04 11.05 11.06 11.07 11.08 11.09 11.10 11.11 Wallace DV, Dykewicz MS, Bernstein DI, Blessing-Moore J, Cox L, Khan DA; et al. (2008). “The diagnosis and management of rhinitis: an updated practice parameter”. J Allergy Clin Immunol. 122 (2 Suppl): S1–84. doi:10.1016/j.jaci.2008.06.003. PMID 18662584.
- ↑ 12.0 12.1 12.2 12.3 12.4 Baroody FM (2016). “Nonallergic Rhinitis: Mechanism of Action”. Immunol Allergy Clin North Am. 36 (2): 279–87. doi:10.1016/j.iac.2015.12.005. PMID 27083102.
- ↑ 13.0 13.1 13.2 Kaliner MA (2011). “Nonallergic rhinopathy (formerly known as vasomotor rhinitis)”. Immunol Allergy Clin North Am. 31 (3): 441–55. doi:10.1016/j.iac.2011.05.007. PMID 21737036.
- ↑ 14.0 14.1 Sin B, Togias A (2011). “Pathophysiology of allergic and nonallergic rhinitis”. Proc Am Thorac Soc. 8 (1): 106–14. doi:10.1513/pats.201008-057RN. PMID 21364228.
- ↑ Kurklinsky AK, Miller VM, Rooke TW (2011). “Acrocyanosis: the Flying Dutchman”. Vasc Med. 16 (4): 288–301. doi:10.1177/1358863X11398519. PMC 3156491. PMID 21427140.
- ↑ Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A; et al. (2008). “Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)”. Allergy. 63 Suppl 86: 8–160. doi:10.1111/j.1398-9995.2007.01620.x. PMID 18331513.
- ↑ Segal S, Shlamkovitch N, Eviatar E, Berenholz L, Sarfaty S, Kessler A (1999). “Vasomotor rhinitis following trauma to the nose”. Ann Otol Rhinol Laryngol. 108 (2): 208–10. PMID 10030243.
- ↑ 18.0 18.1 Monteseirin J, Camacho MJ, Bonilla I, Sánchez-Hernández C, Hernández M, Conde J (2001). “Honeymoon rhinitis”. Allergy. 56 (4): 353–4. PMID 11284809.
- ↑ 19.0 19.1 19.2 Georgalas C, Jovancevic L (2012). “Gustatory rhinitis”. Curr Opin Otolaryngol Head Neck Surg. 20 (1): 9–14. doi:10.1097/MOO.0b013e32834dfb52. PMID 22143339.
- ↑ 20.0 20.1 20.2 20.3 Jovancevic L, Georgalas C, Savovic S, Janjevic D (2010). “Gustatory rhinitis”. Rhinology. 48 (1): 7–10. doi:10.4193/Rhin07.153. PMID 20502728.
- ↑ 21.00 21.01 21.02 21.03 21.04 21.05 21.06 21.07 21.08 21.09 Romeo, Jonathan; Dykewicz, Mark (2014). “Chapter 9:Differential Diagnosis of Rhinitis and Rhinosinusitis”. Diseases of the Sinuses. Springer New York. pp. 133–152. ISBN 978-1-4939-0265-1.
- ↑ 22.0 22.1 22.2 Ellis AK, Keith PK (2007). “Nonallergic rhinitis with eosinophilia syndrome and related disorders”. Clin Allergy Immunol. 19: 87–100. PMID 17153009.
- ↑ 23.0 23.1 23.2 Stevens WW, Grammer LC (2015). “Occupational rhinitis: an update”. Curr Allergy Asthma Rep. 15 (1): 487. doi:10.1007/s11882-014-0487-8. PMID 25430949.
- ↑ 24.0 24.1 24.2 Nozad CH, Michael LM, Betty Lew D, Michael CF (2010). “Non-allergic rhinitis: a case report and review”. Clin Mol Allergy. 8: 1. doi:10.1186/1476-7961-8-1. PMC 2835646. PMID 20181075.
- ↑ 25.00 25.01 25.02 25.03 25.04 25.05 25.06 25.07 25.08 25.09 25.10 25.11 Caparroz FA, Gregorio LL, Bongiovanni G, Izu SC, Kosugi EM (2016). “Rhinitis and pregnancy: literature review”. Braz J Otorhinolaryngol. 82 (1): 105–11. doi:10.1016/j.bjorl.2015.04.011. PMID 26601995.
- ↑ Doshi J (2009). “Rhinitis medicamentosa: what an otolaryngologist needs to know”. Eur Arch Otorhinolaryngol. 266 (5): 623–5. doi:10.1007/s00405-008-0896-1. PMID 19096862.
- ↑ 27.0 27.1 Varghese M, Glaum MC, Lockey RF (2010). “Drug-induced rhinitis”. Clin Exp Allergy. 40 (3): 381–4. doi:10.1111/j.1365-2222.2009.03450.x. PMID 20210811.
- ↑ Bist SS, Bisht M, Purohit JP (2012). “Primary atrophic rhinitis: a clinical profile, microbiological and radiological study”. ISRN Otolaryngol. 2012: 404075. doi:10.5402/2012/404075. PMC 3671697. PMID 23762613.
- ↑ Shehata MA (1996). “Atrophic rhinitis”. Am J Otolaryngol. 17 (2): 81–6. PMID 8820180.
- ↑ 30.0 30.1 30.2 Teberg A, Hodgman JE (1973). “Congenital syphilis in newborn”. Calif Med. 118 (4): 5–10. PMC 1455023. PMID 4692180.
Causes
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Fatimo Biobaku M.B.B.S [2]
Overview
One of the most common diseases presenting to physicians is chronic rhinitis, and determination of the etiology is crucial to ensure appropriate management.[1] Allergic rhinitis is the most common type of chronic rhinitis,[2][3] and it has been estimated as the fifth most common chronic ailment overall in the U.S.[3] Allergic rhinitis is triggered by the inhalation of indoor and outdoor aeroallergens such as pollens, molds, and animal dander.[4][5] Nonallergic rhinitis comprises a heterogenous group of disorders, some of which are still poorly defined and understood.[6] Nonallergic rhinitis can be induced by non-specific triggers such as exposure to chemical odors, cigarette smoke, spicy food, exercise, and cold air.[7]
Causes
Common Causes
- Allergic rhinitis- This is the most common cause of chronic rhinitis.[8] The common triggers are listed in the table below.
- Infectious rhinitis- This is the most common cause of nonallergic rhinitis in children.[9] 98% of acute infectious rhinitis are due to viral upper respiratory infections.[10] It is commonly associated with sinusitis (rhinosinusitis).[11] Symptoms usually resolve within 7-10 days of onset.[11] Common viruses implicated are rhinoviruses, influenza viruses and parainfluenza viruses.[12]
- Vasomotor rhinitis– This is the most common type of nonallergic rhinitis in the adult population.[13][6] The causes of vasomotor rhinitis are listed below.
| Class | Causes of Rhinitis[10][14][11][4] |
|---|---|
| Allergic rhinitis | Indoor and outdoor substances such as:
|
| Nonallergic rhinitis | Vasomotor rhinitis |
Gustatory rhinitis- Triggered by solid/liquid food ingestion such as
| |
| Infectious | |
| Occupational rhinitis | Caused by protein and chemical allergens, chemical respiratory sensitizers, or unknown mechanisms
|
| Other rhinitis syndrome | Hormonally induced
|
Drug-induced[18]
| |
Primary atrophic rhinitis– causes include:
Secondary atrophic rhinitis– causes include:
| |
Rhinitis associated with inflammatory-immunologic disorders
|
Causes by Organ System
| Cardiovascular | No underlying causes |
| Chemical/Poisoning | No underlying causes |
| Dental | No underlying causes |
| Dermatologic | No underlying causes |
| Drug Side Effect | Aspirin, NSAID, Clonidine, Guanfacine, Methyldopa, Moxonidine, Rescinnamine, Reserpine, Rilmenidine, Mecamylamine, Trimethaphan,Prazosin, Guanethidine, Indoramin, Doxazosin, Phentolamine, Sildenafil, Tadalafil, Vardenafil, Amiloride, ACE inhibitors, oral Beta blockers, intraocular beta blockers, calcium channel blockers, Chlorothiazide, Hydralazine, Hydrochlorothiazide, Exogenous estrogens, oral contraceptives, Chlordiazepoxide-Amitryptiline, Chlorpromazine, Risperidone, Thioridazine, Gabapentin,Butorphanol, Cefpodoxime, Desmopressin, Dimercaprol, Dornase Alfa, Flunisolide, Flurbiprofen, Ivacaftor, Moxifloxacin ophthalmic, Nilutamide, Rifaximin, Rimexolone, Sertraline, Tamsulosin, Trichophyton mentagrophytes and Trichophyton rubrum, Thalidomide, Tizanidine, Topiramate |
| Ear Nose Throat | Upper respiratory tract infections– Viral, Bacterial, Fungal and Parasitic |
| Endocrine | No underlying causes |
| Environmental | Pollens, molds, animal dander, coakroach residues, dust mite fecal particles |
| Gastroenterologic | No underlying causes |
| Genetic | Genetic predisposition(Allergic rhinitis) |
| Hematologic | No underlying causes |
| Iatrogenic | Secondary atrophic rhinitis (Surgical removal of nasal turbinates, Radiation) |
| Infectious Disease | Rhinovirus, Adenovirus, Influenza and Parainfluenza viruses, Klebsiella ozaenae, Klebsiella rhinoscleromatis, Syphilis |
| Musculoskeletal/Orthopedic | No underlying causes |
| Neurologic | No underlying causes |
| Nutritional/Metabolic | No underlying causes |
| Obstetric/Gynecologic | No underlying causes |
| Oncologic | Midline granuloma |
| Ophthalmologic | No underlying causes |
| Overdose/Toxicity | No underlying causes |
| Psychiatric | No underlying causes |
| Pulmonary | No underlying causes |
| Renal/Electrolyte | No underlying causes |
| Rheumatology/Immunology/Allergy | Pollens, Animal danders, Molds, Protein and chemical allergens |
| Sexual | No underlying causes |
| Trauma | Nose trauma |
| Urologic | No underlying causes |
| Miscellaneous | No underlying causes |
References
- ↑ Settipane RA, Charnock DR (2007). “Epidemiology of rhinitis: allergic and nonallergic”. Clin Allergy Immunol. 19: 23–34. PMID 17153005.
- ↑ Sacre-Hazouri JA (2012). “[Chronic rhinosinusitis in children]”. Rev Alerg Mex. 59 (1): 16–24. PMID 24007929.
- ↑ 3.0 3.1 Seidman MD, Gurgel RK, Lin SY, Schwartz SR, Baroody FM, Bonner JR; et al. (2015). “Clinical practice guideline: allergic rhinitis executive summary”. Otolaryngol Head Neck Surg. 152 (2): 197–206. doi:10.1177/0194599814562166. PMID 25645524.
- ↑ 4.0 4.1 Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A; et al. (2008). “Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)”. Allergy. 63 Suppl 86: 8–160. doi:10.1111/j.1398-9995.2007.01620.x. PMID 18331513.
- ↑ Dykewicz MS, Hamilos DL (2010). “Rhinitis and sinusitis”. J Allergy Clin Immunol. 125 (2 Suppl 2): S103–15. doi:10.1016/j.jaci.2009.12.989. PMID 20176255.
- ↑ 6.0 6.1 Sin B, Togias A (2011). “Pathophysiology of allergic and nonallergic rhinitis”. Proc Am Thorac Soc. 8 (1): 106–14. doi:10.1513/pats.201008-057RN. PMID 21364228.
- ↑ Paraskevopoulos, Giannis; Kalogiros, Lampros (March 2016). “Non-Allergic Rhinitis”. Current Treatment Options in Allergy. Volume 3 (Issue 1): 45–68. doi:10.1007/s40521-016-0072-6. Retrieved January 5, 2017.
- ↑ Dykewicz MS, Hamilos DL (2010). “Rhinitis and sinusitis”. J Allergy Clin Immunol. 125 (2 Suppl 2): S103–15. doi:10.1016/j.jaci.2009.12.989. PMID 20176255 20176255 Check
|pmid=value (help). - ↑ Skoner DP (2001). “Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis”. J Allergy Clin Immunol. 108 (1 Suppl): S2–8. PMID 11449200.
- ↑ 10.0 10.1 Wallace DV, Dykewicz MS, Bernstein DI, Blessing-Moore J, Cox L, Khan DA; et al. (2008). “The diagnosis and management of rhinitis: an updated practice parameter”. J Allergy Clin Immunol. 122 (2 Suppl): S1–84. doi:10.1016/j.jaci.2008.06.003. PMID 18662584.
- ↑ 11.0 11.1 11.2 Romeo, Jonathan; Dykewicz, Mark (2014). “Chapter 9:Differential Diagnosis of Rhinitis and Rhinosinusitis”. Diseases of the Sinuses. Springer New York. pp. 133–152. ISBN 978-1-4939-0265-1.
- ↑ Brook I (2011). “Microbiology of sinusitis”. Proc Am Thorac Soc. 8 (1): 90–100. doi:10.1513/pats.201006-038RN. PMID 21364226.
- ↑ Pattanaik D, Lieberman P (2010). “Vasomotor rhinitis”. Curr Allergy Asthma Rep. 10 (2): 84–91. doi:10.1007/s11882-010-0089-z. PMID 20425499.
- ↑ Kaliner MA (2011). “Nonallergic rhinopathy (formerly known as vasomotor rhinitis)”. Immunol Allergy Clin North Am. 31 (3): 441–55. doi:10.1016/j.iac.2011.05.007. PMID 21737036.
- ↑ 15.0 15.1 15.2 15.3 Katelaris CH, Lee BW, Potter PC, Maspero JF, Cingi C, Lopatin A; et al. (2012). “Prevalence and diversity of allergic rhinitis in regions of the world beyond Europe and North America”. Clin Exp Allergy. 42 (2): 186–207. doi:10.1111/j.1365-2222.2011.03891.x. PMID 22092947.
- ↑ Segal S, Shlamkovitch N, Eviatar E, Berenholz L, Sarfaty S, Kessler A (1999). “Vasomotor rhinitis following trauma to the nose”. Ann Otol Rhinol Laryngol. 108 (2): 208–10. PMID 10030243.
- ↑ Monteseirin J, Camacho MJ, Bonilla I, Sánchez-Hernández C, Hernández M, Conde J (2001). “Honeymoon rhinitis”. Allergy. 56 (4): 353–4. PMID 11284809.
- ↑ Varghese M, Glaum MC, Lockey RF (2010). “Drug-induced rhinitis”. Clin Exp Allergy. 40 (3): 381–4. doi:10.1111/j.1365-2222.2009.03450.x. PMID 20210811.
Differentiating Rhinitis from other Diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Fatimo Biobaku M.B.B.S [2]
Overview
Rhinitis is a very common disease that is frequently overlooked or undertreated.[1] It is associated with several comorbidities which can have significant impact on the quality of life. It can also be the initial presentation of overt systemic illnesses which can be potentially fatal.[2] It is important to differentiate rhinitis from other conditions micmicking the symptoms of rhinitis such as intranasal foreign bodies, cerebrospinal fluid rhinorrhea, nasal polyps and tumors.
Differential Diagnosis
The following conditions can present with symptoms that are similar to those found in rhinitis:[3][4][5][6]
- Nasal polyps
- Mechanical/structural factors such as:
- Deviated nasal septum/septal wall anomalies
- Adenoidal hypertrophy
- Nasal tumors (benign and malignant)
- Foreign bodies- Unilateral, mucopurulent rhinorrhea in children could be as a result of insertion of foreign objects into the nostril.
- Trauma
- Anatomical variants in the ostiomeatal complex
- Choanal atresia
- Cleft palate
- Pharyngeal reflux (laryngopharyngo-nasal reflux)
- Metabolic conditions such as acromegaly
- Cerebrospinal fluid rhinorrhea: In cases where CSF rhinorrhea is suspected, the rhinorrhea can be evaluated for beta-2 transferrin (beta-2 transferrin is an endogenous marker of CSF leakage).
- Ciliary dyskinesia syndrome: Chronic rhinitis with mucopurulent secretion which manifests from birth could be suggestive of primary ciliary dyskinesia.
| Disease | History | Physical examination | Laboratory or radiological findings |
|---|---|---|---|
| Acute viral nasopharyngitis[7] |
|
|
|
| Allergic rhinitis[8] |
|
|
|
| Acute sinusitis[9] |
|
|
|
| Infectious mononucleosis[11] |
|
|
|
References
- ↑ 1.0 1.1 Skoner DP (2001). “Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis”. J Allergy Clin Immunol. 108 (1 Suppl): S2–8. PMID 11449200.
- ↑ Romeo, Jonathan; Dykewicz, Mark (2014). “Chapter 9:Differential Diagnosis of Rhinitis and Rhinosinusitis”. Diseases of the Sinuses. Springer New York. pp. 133–152. ISBN 978-1-4939-0265-1.
- ↑ Dykewicz MS, Hamilos DL (2010). “Rhinitis and sinusitis”. J Allergy Clin Immunol. 125 (2 Suppl 2): S103–15. doi:10.1016/j.jaci.2009.12.989. PMID 20176255 20176255 Check
|pmid=value (help). - ↑ Sacre-Hazouri JA (2012). “[Chronic rhinosinusitis in children]”. Rev Alerg Mex. 59 (1): 16–24. PMID 24007929.
- ↑ Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A; et al. (2008). “Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)”. Allergy. 63 Suppl 86: 8–160. doi:10.1111/j.1398-9995.2007.01620.x. PMID 18331513.
- ↑ Rotiroti, Giuseppina; Scadding, Glenis (July 2016). “Allergic Rhinitis-an overview of a common disease”. Paediatrics and Child Health. Volume 26 (Issue 7): 298–303. Retrieved January 20, 2017.
- ↑ Heikkinen T, Järvinen A (2003). “The common cold”. Lancet. 361 (9351): 51–9. doi:10.1016/S0140-6736(03)12162-9. PMID 12517470.
- ↑ Pawankar R, Bunnag C, Chen Y, Fukuda T, Kim YY, Le LT, Huong le TT, O’Hehir RE, Ohta K, Vichyanond P, Wang DY, Zhong N, Khaltaev N, Bousquet J (2009). “Allergic rhinitis and its impact on asthma update (ARIA 2008)–western and Asian-Pacific perspective”. Asian Pac. J. Allergy Immunol. 27 (4): 237–43. PMID 20232579.
- ↑ Low DE, Desrosiers M, McSherry J, Garber G, Williams JW, Remy H, Fenton RS, Forte V, Balter M, Rotstein C, Craft C, Dubois J, Harding G, Schloss M, Miller M, McIvor RA, Davidson RJ (1997). “A practical guide for the diagnosis and treatment of acute sinusitis”. CMAJ. 156 Suppl 6: S1–14. PMID 9347786.
- ↑ “Acute maxillary sinusitis”. N. Engl. J. Med. 305 (4): 226–7. 1981. doi:10.1056/NEJM198107233050419. PMID 7242607.
- ↑ Niederman JC, McCollum RW, Henle G, Henle W (1968). “Infectious mononucleosis. Clinical manifestations in relation to EB virus antibodies”. JAMA. 203 (3): 205–9. PMID 4864269.
Epidemiology and Demographics
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Fatimo Biobaku M.B.B.S [2]
Overview
Rhinitis is a very frequent and highly prevalent global disease, and it is one of the most common conditions presenting for medical care in developed countries.[1]
Epidemiology and Demographics
Prevalence
Rhinitis is a highly prevalent disease with significant financial impact on the society.[2] Chronic rhinitis is one of the most common problems seen by physicians.[1] Allergic rhinitis is estimated to affect one in every six Americans, and it is the fifth most chronic disease in the U.S.[3] Allergic rhinitis is the most common chronic disease in the pediatric age group in the U.S,[3] and it was the most common diagnosis reported in the 2000 Otolaryngology Workforce study.[4] The estimated prevalence of allergic rhinitis ranges from 9-42%.[5] Annually, between 30-60 million people in the U.S suffer from allergic rhinitis, 10-30% of these individuals are adults, and up to 40% are children.[1] The prevalence of allergic rhinitis has been found to be increasing in countries worldwide, and factors such as increased airborne pollution, a rise in the population of dust mite in inadequately ventilated offices/homes with central heating/air conditioning, and sedentary lifestyles, have been suggested to contribute to the rise in its prevalence.[6][7][8] The prevalence of allergic rhinitis has significantly increased during the past 50 years, with over 50% of adolecents in some countries reporting symptoms of allergic rhinitis.[7] The prevalence of allergic rhinitis was noticed to have doubled in several countries over the last two decades in studies done in children between the ages 6-14years around the globe.[8] Nonallergic rhinitis is also very common, and it has been estimated to affect about 19 million people in the U.S.[5] There is sometimes an overlap between allergic and nonallergic rhinitis, referred to as “mixed rhinitis”, and this has been estimated to affect about 26 million individuals in the United States.[5] The overall prevalence of occupational rhinitis is unknown but it has been estimated to affect between 23-50% of bakers in Norway.[9]
Age
Rhinitis affects all age groups. Allergic rhinitis is the most common chronic disease of childhood,[10] with symptoms developing in one of five children by 2-3 years of age.[11] Up to 40% of of children have symptoms of allergic rhinitis by the age of six.[11] The onset of nonallergic (non-infectious) rhinitis is often after the age of 20 years.[5] Primary atrophic rhinitis is more commonly seen in young to middle-aged adults.[12]
| Pattern of Allergic and Infectious rhinitis in children[10] | ||
|---|---|---|
| Age | Allergic rhinitis | Infectious rhinitis |
| Neonates and Infants | +/- | ++ |
| Pre-school age | ++ | ++ |
| School age | +++ | ++ |
| Pre-adolescent | +++ | + |
Sex
- Allergic rhinitis appears to be more common in boys during childhood, but males and females are equally affected during adulthood.[11]
- Nonallergic (non-infectious) rhinitis is predominantly seen in females.[5]
- Primary atrophic rhinitis is more common in females, with a female:male ratio of 5.6:1.[13]
Geographical Distribution
Rhinitis is a global disease with wide inter-regional and intra-regional variations in its prevalence.[8] A study on the prevalence and diversity of allergic rhinitis in regions of the world (several countries in Africa, the Asia-Pacific region, Australia, Eastern Europe, Latin America, Middle East and Turkey), showed wide variations in the prevalence of allergic rhinitis, ranging from 2.9% to 54.1%.[8] Primary atrophic rhinitis is more prevalent in developing countries with warm climates.[12] The prevalence of primary atrophic rhinitis varies in different parts of the world, affecting about 0.3-1% of the population in countries where it is highly prevalent.[13] It has been found to be a common condition in tropical countries like India.[13]
Cost
Chronic rhinitis constitute a huge financial burden to the society.[2] Allergic rhinitis generates between $1.6-$4.9 billion in direct healthcare expenditure in the United States, and an indirect cost of about $0.1-$9.7 billion due to lost productivity annually.[4]
References
- ↑ 1.0 1.1 1.2 Romeo, Jonathan; Dykewicz, Mark (2014). “Chapter 9:Differential Diagnosis of Rhinitis and Rhinosinusitis”. Diseases of the Sinuses. Springer New York. pp. 133–152. ISBN 978-1-4939-0265-1.
- ↑ 2.0 2.1 Wallace DV, Dykewicz MS, Bernstein DI, Blessing-Moore J, Cox L, Khan DA; et al. (2008). “The diagnosis and management of rhinitis: an updated practice parameter”. J Allergy Clin Immunol. 122 (2 Suppl): S1–84. doi:10.1016/j.jaci.2008.06.003. PMID 18662584.
- ↑ 3.0 3.1 Seidman MD, Gurgel RK, Lin SY, Schwartz SR, Baroody FM, Bonner JR; et al. (2015). “Clinical practice guideline: allergic rhinitis executive summary”. Otolaryngol Head Neck Surg. 152 (2): 197–206. doi:10.1177/0194599814562166. PMID 25645524.
- ↑ 4.0 4.1 Mims JW (2014). “Epidemiology of allergic rhinitis”. Int Forum Allergy Rhinol. 4 Suppl 2: S18–20. doi:10.1002/alr.21385. PMID 25182349.
- ↑ 5.0 5.1 5.2 5.3 5.4 Settipane RA, Charnock DR (2007). “Epidemiology of rhinitis: allergic and nonallergic”. Clin Allergy Immunol. 19: 23–34. PMID 17153005.
- ↑ Schoenwetter WF, Dupclay L, Appajosyula S, Botteman MF, Pashos CL (2004). “Economic impact and quality-of-life burden of allergic rhinitis”. Curr Med Res Opin. 20 (3): 305–17. doi:10.1185/030079903125003053. PMID 15025839.
- ↑ 7.0 7.1 Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A; et al. (2008). “Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)”. Allergy. 63 Suppl 86: 8–160. doi:10.1111/j.1398-9995.2007.01620.x. PMID 18331513.
- ↑ 8.0 8.1 8.2 8.3 Katelaris CH, Lee BW, Potter PC, Maspero JF, Cingi C, Lopatin A; et al. (2012). “Prevalence and diversity of allergic rhinitis in regions of the world beyond Europe and North America”. Clin Exp Allergy. 42 (2): 186–207. doi:10.1111/j.1365-2222.2011.03891.x. PMID 22092947.
- ↑ Stevens WW, Grammer LC (2015). “Occupational rhinitis: an update”. Curr Allergy Asthma Rep. 15 (1): 487. doi:10.1007/s11882-014-0487-8. PMID 25430949.
- ↑ 10.0 10.1 Rotiroti, Giuseppina; Scadding, Glenis (July 2016). “Allergic Rhinitis-an overview of a common disease”. Paediatrics and Child Health. Volume 26 (Issue 7): 298–303. Retrieved January 20, 2017.
- ↑ 11.0 11.1 11.2 Skoner DP (2001). “Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis”. J Allergy Clin Immunol. 108 (1 Suppl): S2–8. PMID 11449200.
- ↑ 12.0 12.1 Dykewicz MS, Hamilos DL (2010). “Rhinitis and sinusitis”. J Allergy Clin Immunol. 125 (2 Suppl 2): S103–15. doi:10.1016/j.jaci.2009.12.989. PMID 20176255.
- ↑ 13.0 13.1 13.2 Bist SS, Bisht M, Purohit JP (2012). “Primary atrophic rhinitis: a clinical profile, microbiological and radiological study”. ISRN Otolaryngol. 2012: 404075. doi:10.5402/2012/404075. PMC 3671697. PMID 23762613.
Risk Factors
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Fatimo Biobaku M.B.B.S [2]
Overview
Several studies have identified risk factors associated with some forms of rhinitis such as allergic rhinitis. However, the nonallergic (non-infectious) rhinitis still requires more research to better understand the disease and its associated risk factors.[1]
Risk Factors
The risk factors for allergic rhinitis include the following:[2][3]
- The presence of other allergic diseases such as asthma, eczema
- Parental rhinitis
- Allergic sensitization to common household aeroallergens
- Obesity/being overweight
- Elevated exhaled Nitric oxide
- High total serum IgE
- Exposure to parental smoking
- Exposure to pets
- Genetic predisposition[4]
- Exposure to fossil fuel and traffic related pollutants[4]
- Increased dampness and poor ventilation from tightly insulated modern homes (increases sensitization and allergy to molds)[4]
- Early introduction of infants to formula/food[5]
Risk factors for infectious rhinitis include:[6]
- Young age
- Daycare attendance
- Exposure to tobacco smoke/air pollutants
- Deficient immunity
- Crowding conditions
Increased risk of occupational rhinitis has been found in the following professions:[7][8]
- Furriers
- Bakers
- Livestock breeders
- Food-processing workers
- Veterinarians
- Farmers
- Electronic product assemblers
- Boat builders
References
- ↑ Bousquet J, Fokkens W, Burney P, Durham SR, Bachert C, Akdis CA; et al. (2008). “Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper”. Allergy. 63 (7): 842–53. doi:10.1111/j.1398-9995.2008.01715.x. PMID 18588549.
- ↑ Baumann LM, Romero KM, Robinson CL, Hansel NN, Gilman RH, Hamilton RG; et al. (2015). “Prevalence and risk factors for allergic rhinitis in two resource-limited settings in Peru with disparate degrees of urbanization”. Clin Exp Allergy. 45 (1): 192–9. doi:10.1111/cea.12379. PMID 25059756.
- ↑ Song N, Shamssain M, Mohammed S, Zhang J, Wu J, Fu C; et al. (2014). “Prevalence, severity and risk factors of asthma, rhinitis and eczema in a large group of Chinese schoolchildren”. J Asthma. 51 (3): 232–42. doi:10.3109/02770903.2013.867973. PMID 24303994.
- ↑ 4.0 4.1 4.2 Katelaris CH, Lee BW, Potter PC, Maspero JF, Cingi C, Lopatin A; et al. (2012). “Prevalence and diversity of allergic rhinitis in regions of the world beyond Europe and North America”. Clin Exp Allergy. 42 (2): 186–207. doi:10.1111/j.1365-2222.2011.03891.x. PMID 22092947.
- ↑ Skoner DP (2001). “Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis”. J Allergy Clin Immunol. 108 (1 Suppl): S2–8. PMID 11449200.
- ↑ Passioti M, Maggina P, Megremis S, Papadopoulos NG (2014). “The common cold: potential for future prevention or cure”. Curr Allergy Asthma Rep. 14 (2): 413. doi:10.1007/s11882-013-0413-5. PMID 24415465.
- ↑ Stevens WW, Grammer LC (2015). “Occupational rhinitis: an update”. Curr Allergy Asthma Rep. 15 (1): 487. doi:10.1007/s11882-014-0487-8. PMID 25430949.
- ↑ Hytönen M, Kanerva L, Malmberg H, Martikainen R, Mutanen P, Toikkanen J (1997). “The risk of occupational rhinitis”. Int Arch Occup Environ Health. 69 (6): 487–90. PMID 9215937.
Natural History, Complications and Prognosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Fatimo Biobaku M.B.B.S [2]
Overview
Rhinitis is a heterogeneous group of disorders that can significantly impact the quality of life of the affected individual[1] A heightened awareness of the condition and its potential debilitating comorbidities/complications is essential for a timely intervention.[1][2]
Natural History, Complications, Prognosis
Natural History
Rhinitis is a very common disease, and it is sometimes erroneously viewed as a trivial disease.[3][1] Allergic rhinitis rarely occurs in isolation, it is a product of a genetic predisposition, epigenetic events, and environmental exposures, and it is frequently associated with other forms of atopy such as eczema, asthma, and allergic eye disease(allergic rhinoconjunctivitis).[4][5][6] The vast majority of individuals with asthma have rhinitis, and allergic eye disease has been reported to affect almost all patients with allergic rhinitis.[4][7] Nonallergic rhinitis is also associated with asthma.[8][7] Frequent extension of rhinitis into the sinuses also occur, resulting in rhinosinusitis.[9][1] Children with nonallergic rhinitis have a higher likelihood of undergoing remission, compared with those with allergic rhinitis, who tend to have a more persistent disease.[8] Remission occurs in up to 73% of four year old children with nonallergic rhinitis by the age of eight years.[8] Rhinitis is a significant cause of lost school and work days, and it constitutes a huge financial burden to the society.[10][3] Untreated/poorly treated chronic rhinitis is associated with a diminished quality of life, disordered sleep, impaired work performance, and several other co-morbidities.[1][5]
Complications
The complications of rhinitis include the following:[7][3][11]
- Conjunctivitis
- Rhinosinusitis
- Chronic cough– One of the commonest causes of chronic cough is posterior rhinorrhoea(postnasal drip)
- Fatigue
- Mouth breathing
- Aggravation of adenoidal hypertrophy[12]
- Headache
- Poor sleep
- Obstructive sleep apnea
- Snoring
- Cognitive impairment
- Hyperactivity
- Eustachian tube dysfunction
- Acute otitis media[12]
- Otitis media with effusion
- Aggravation of asthma
- Laryngitis[13]
- Hyposmia (usually mild)
Allergic comorbidities associated with Allergic rhinitis include:[7]
- Allergic eye diseases[4]
- Seasonal allergic conjunctivitis
- Perennial allergic conjunctivitis
- Vernal keratoconjunctivitis
- Atopic keratoconjunctivitis
- Asthma: Allergic rhinitis is strongly associated with the risk of developing asthma, and the coexistence of rhinitis with asthma is often associated with an increase in asthma severity.[14]
- Atopic dermatitis
- Oral allergy syndrome[15]
- Eosinophilic gastroenteritis[16]
Prognosis
Resolution of allergic rhinitis occurs in only 10-20% of children within 10 years.[17] A higher likelihood of remission has been documented in children with nonallergic rhinitis compared to the allergic type, with remission occurring within four years in about 73% of four year old children suffering from nonallergic rhinitis.[8] Poorly treated rhinitis is strongly associated with a decreased quality of life and several other co-morbidities.[1]
References
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 Romeo, Jonathan; Dykewicz, Mark (2014). “Chapter 9:Differential Diagnosis of Rhinitis and Rhinosinusitis”. Diseases of the Sinuses. Springer New York. pp. 133–152. ISBN 978-1-4939-0265-1.
- ↑ Skoner DP (2001). “Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis”. J Allergy Clin Immunol. 108 (1 Suppl): S2–8. PMID 11449200.
- ↑ 3.0 3.1 3.2 Wallace DV, Dykewicz MS, Bernstein DI, Blessing-Moore J, Cox L, Khan DA; et al. (2008). “The diagnosis and management of rhinitis: an updated practice parameter”. J Allergy Clin Immunol. 122 (2 Suppl): S1–84. doi:10.1016/j.jaci.2008.06.003. PMID 18662584.
- ↑ 4.0 4.1 4.2 Shaker M, Salcone E (2016). “An update on ocular allergy”. Curr Opin Allergy Clin Immunol. 16 (5): 505–10. doi:10.1097/ACI.0000000000000299. PMID 27490123.
- ↑ 5.0 5.1 Sacre Hazouri JA (2006). “[Allergic rhinitis. Coexistent diseases and complications. A review and analysis]”. Rev Alerg Mex. 53 (1): 9–29. PMID 16634358.
- ↑ Mims JW (2014). “Epidemiology of allergic rhinitis”. Int Forum Allergy Rhinol. 4 Suppl 2: S18–20. doi:10.1002/alr.21385. PMID 25182349.
- ↑ 7.0 7.1 7.2 7.3 Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A; et al. (2008). “Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)”. Allergy. 63 Suppl 86: 8–160. doi:10.1111/j.1398-9995.2007.01620.x. PMID 18331513.
- ↑ 8.0 8.1 8.2 8.3 Westman M, Stjärne P, Asarnoj A, Kull I, van Hage M, Wickman M; et al. (2012). “Natural course and comorbidities of allergic and nonallergic rhinitis in children”. J Allergy Clin Immunol. 129 (2): 403–8. doi:10.1016/j.jaci.2011.09.036. PMID 22056609.
- ↑ Dykewicz MS, Hamilos DL (2010). “Rhinitis and sinusitis”. J Allergy Clin Immunol. 125 (2 Suppl 2): S103–15. doi:10.1016/j.jaci.2009.12.989. PMID 20176255.
- ↑ Schoenwetter WF, Dupclay L, Appajosyula S, Botteman MF, Pashos CL (2004). “Economic impact and quality-of-life burden of allergic rhinitis”. Curr Med Res Opin. 20 (3): 305–17. doi:10.1185/030079903125003053. PMID 15025839.
- ↑ Blaiss MS (2008). “Pediatric allergic rhinitis: physical and mental complications”. Allergy Asthma Proc. 29 (1): 1–6. doi:10.2500/aap2008.29.3072. PMID 18302831.
- ↑ 12.0 12.1 Sih T, Mion O (2010). “Allergic rhinitis in the child and associated comorbidities”. Pediatr Allergy Immunol. 21 (1 Pt 2): e107–13. doi:10.1111/j.1399-3038.2009.00933.x. PMID 19664013.
- ↑ Turley R, Cohen SM, Becker A, Ebert CS (2011). “Role of rhinitis in laryngitis: another dimension of the unified airway”. Ann Otol Rhinol Laryngol. 120 (8): 505–10. PMID 21922973.
- ↑ Deliu M, Belgrave D, Simpson A, Murray CS, Kerry G, Custovic A (2014). “Impact of rhinitis on asthma severity in school-age children”. Allergy. 69 (11): 1515–21. doi:10.1111/all.12467. PMC 4209798. PMID 24958195.
- ↑ Rotiroti, Giuseppina; Scadding, Glenis (July 2016). “Allergic Rhinitis-an overview of a common disease”. Paediatrics and Child Health. Volume 26 (Issue 7): 298–303. Retrieved January 20, 2017.
- ↑ Baig MA, Qadir A, Rasheed J (2006). “A review of eosinophilic gastroenteritis”. J Natl Med Assoc. 98 (10): 1616–9. PMC 2569760. PMID 17052051 17052051 Check
|pmid=value (help). - ↑ Sly RM (1999). “Changing prevalence of allergic rhinitis and asthma”. Ann Allergy Asthma Immunol. 82 (3): 233–48, quiz 248-52. doi:10.1016/S1081-1206(10)62603-8. PMID 10094214.
Diagnosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | Other Diagnostic Studies
Treatment
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
